FTXH ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
BMY	B	1.10	8.89
JNJ	D	-0.21	6.95
PFE	D	2.07	6.81
ABBV	D	3.04	6.56
MRK	F	-0.68	6.31
GILD	C	0.48	4.43
CAH	B	-1.28	4.09
VTRS	A	0.91	3.97
UTHR	C	1.51	3.90
ZTS	D	0.14	3.61
JAZZ	B	1.25	3.45
AMGN	D	1.60	3.37
LLY	F	-0.25	3.11
BIIB	F	-0.07	3.06
REGN	F	-0.87	2.51
CRL	C	0.81	2.47
OGN	D	2.62	2.43
ELAN	D	-0.30	1.83
MEDP	D	-1.19	1.79
NBIX	C	0.52	1.39
HALO	F	7.22	1.19
EXEL	B	2.24	1.12
ALKS	B	3.90	1.06
PBH	A	0.84	0.98
PRGO	B	3.66	0.97
CORT	B	2.90	0.82
ACLX	C	3.69	0.73
PTGX	C	11.55	0.71
TGTX	B	1.51	0.69
ALNY	D	-0.77	0.65
ITCI	C	0.28	0.63
ADMA	B	-0.56	0.62
INCY	C	1.89	0.62
RNA	D	1.62	0.60
AMRX	C	0.84	0.55
VCEL	B	4.23	0.54
ACAD	D	1.17	0.54
BPMC	C	-2.56	0.53
VRTX	F	0.13	0.51
KYMR	D	3.38	0.50
ROIV	C	6.01	0.50
INSM	C	-0.89	0.49
TWST	D	1.37	0.48
KRYS	B	4.45	0.48
EXAS	D	-0.30	0.44
VKTX	F	1.86	0.44
BMRN	D	1.28	0.43
SRPT	D	3.38	0.42
IONS	F	0.21	0.41
MYGN	F	2.45	0.29

Represented by ETF Holdings

Keywords: Biopharmaceutical Biotechnology Medicine S&P 500 Pharmaceutical Products Cancer Diabetes Life Sciences Infectious Diseases Pain Clinical Development Immunology Inflammation Schizophrenia Animal Health Autoimmune Disease Depressive Disorder Disease Hypertension Nasdaq 100

Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Distribution Drug Manufacturers - General

Recent News for First Trust Nasdaq Pharmaceuticals ETF & its Holdings

Date	Stock	Title
Nov 23	INCY	What Moved Markets This Week
Nov 23	VRTX	3 Monster Stocks in the Making
Nov 23	JNJ	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 23	MRK	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22	LLY	Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22	MRK	Merck recommends rejection of TRC Capital’s 'mini-tender' offer
Nov 22	ABBV	AbbVie gains on Leerink Partners upgrade to Outperform
Nov 22	MRK	Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer
Nov 22	ABBV	AbbVie: Upgrading To 'Strong Buy' After Pullback
Nov 22	PFE	Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
Nov 22	JNJ	Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22	PFE	BridgeBio heart drug approved by FDA, setting up battle with Pfizer
Nov 22	PFE	Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Nov 22	PFE	FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Nov 22	SRPT	High Growth Tech Stocks to Watch in November 2024
Nov 22	PFE	Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
Nov 22	JNJ	J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22	ABBV	J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22	HALO	Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
Nov 22	JNJ	Medtronic acquires Fortimedix Surgical to boost surgical portfolio

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Nasdaq 100

ETF Components for FTXH - First Trust Nasdaq Pharmaceuticals ETF